Pfizer's Dividend Yield Is 5.7%, Plus Humana And Shake Shack On CNBC's 'Final Trades'

On CNBC’s "Halftime Report Final Trades," Joshua Brown of Ritholtz Wealth Management named Shake Shack Inc SHAK as his final trade.

Shake Shack CEO Randy Garutti recently informed the board of his intention to retire in 2024 after the selection of a successor.

The New York-based burger chain continues to see fourth-quarter revenue of $276.25 million — $281.75 million versus the consensus of $280.48 million.

Stephen Weiss of Short Hills Capital Partners said Humana Inc. HUM has 15 times earnings.

Cigna Group CI reportedly ended its attempt to negotiate an acquisition deal with rival Humana after the pair disagreed on price terms.

Don’t forget to check out our premarket coverage here

Jenny Harrington of Gilman Hill Asset Management said Pfizer Inc. PFE has 5.7% dividend yield and 10 times earnings.

New York-based Pfizer agreed to donate the rights of royalties from sales of cancer drug Bavencio (avelumab) to the American Association for Cancer Research to address U.S. Federal Trade Commission concerns related to its $43-billion deal to buy Seagen Inc SGEN.

Pfizer expects to close the Seagen acquisition on Thursday, Dec. 14.

Shannon Saccocia of Boston Private picked iShares U.S. Healthcare ETF IYH.

Price Action:

• Shake Shack shares gained 0.9% to close at $67.42 on Tuesday.
• Humana gained 1.1% to $481.94.
• Pfizer gained 0.2% to $28.58.
• iShares U.S. Healthcare ETF added 0.6% during Tuesday’s session.

Check This Out: Insiders Buying Delcath Systems And 3 Other Penny Stocks

Image: Shutterstock